Abstract
14-3-3σ is frequently lost in human breast cancers by genetic deletion or promoter methylation. We have now investigated the involvement of 14-3-3σ in the termination of NF-κB signal in mammary cells and its putative role in cancer relapse and metastasis. Our results show that 14-3-3σ regulates nuclear export of p65-NF-κB following chronic TNFα stimulation. Restoration of 14-3-3σ in breast cancer cells reduces migration capacity and metastatic abilities in vivo. By microarray analysis, we have identified a genetic signature that responds to TNFα in a 14-3-3σ-dependent manner and significantly associates with different breast and other types of cancer. By interrogating public databases, we have found that over-expression of this signature correlates with poor relapse-free survival in breast cancer patients. Finally, screening of 96 human breast tumors showed that NF-κB activation strictly correlates with the absence of 14-3-3σ and it is significantly associated with worse prognosis in the multivariate analysis. Our findings identify a genetic signature that is important for breast cancer prognosis and for future personalized treatments based on NF-κB targeting. © 2012 Inglés-Esteve et al.
Cite
CITATION STYLE
Inglés-Esteve, J., Morales, M., Dalmases, A., Garcia-Carbonell, R., Jené-Sanz, A., López-Bigas, N., … Espinosa, L. (2012). Inhibition of specific nf-κb activity contributes to the tumor suppressor function of 14-3-3σ in breast cancer. PLoS ONE, 7(5). https://doi.org/10.1371/journal.pone.0038347
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.